Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › desloratadine

desloratadine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of desloratadine

7 trials tracked of desloratadine: 5 in phase 3 or 4.

7Trials tracked
5Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 4 Phase 3 1 Other / NA 2
  1. Phase 4 The Duration of the Suppressive Effects of Desloratadine on Allergen Prick Tests After Discontinuation (P04441) Completed
  2. Phase 4 CUTE (Chronic Urticaria Treatment Evaluation) Completed
  3. Phase 4 Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) Completed
  4. Phase 4 Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) Completed
  5. Phase 3 An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201) Completed
  6. N/A Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) Completed
Show 1 more trials
  1. N/A Evaluation of Desloratadine When Used in Patients With Either Allergic Rhinitis or Chronic Idiopathic Urticaria Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Montelukast and oral antihistamines improve daytime allergic rhinitis symptoms
Allergy & Immunology Meta-analysis
Montelukast and oral antihistamines improve daytime allergic rhinitis symptoms Combination therapy beats single drug for daytime allergy symptoms
A meta-analysis finds combination therapy significantly improves daytime symptoms in allergic rhinitis, with limited benefits for nighttime …
Combining two common allergy drugs works better for daytime relief than taking just one, but the extra pill might not help you sleep at nigh…
May 5, 2026